According to filings with the U.S. Securities and Exchange Commission, Radical Numerics has raised $50,000,000.00 in new Seed funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

Investors in the company’s current round of funding include: Emergence Capital, Obvious Ventures, Triatomic Capital, Factory and First Spark Ventures.

About Radical Numerics
Radical Numerics is an AI research lab building general biological intelligence: AI that can read, write, and design across all of biology. The company’s founders created the field of generative genomics with Evo, the first model to enable the design of DNA with large language models and the largest fully open-source biological AI project in history. Radical Numerics holds a dual mandate: to advance biological design for human health and build the biodefenses to protect it.

To learn more, visit https://www.radicalnumerics.ai/
Linkedin: https://www.linkedin.com/company/radical-numerics/

Contact:
Eric Nguyen, Chief Executive Officer
https://www.linkedin.com/in/nguyenstanford/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.